Emergex Vaccines
-
Emergex Vaccines expands at Milton Park
Emergex Vaccines, which focuses on the development of synthetic T-cell vaccines against global infectious disease threats has expanded at Milton Park.
Emergex Vaccines, which focuses on the development of synthetic T-cell vaccines against global infectious disease threats has expanded at Milton Park.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.